Sekisui Diagnostics, Qualigen to Market FastPack

Sekisui Diagnostics has entered into a strategic partnership with Qualigen to market and distribute Qualigen’s FastPack IP System, the companies announced Tuesday.

The immunoassay system analyzes blood to provide quantitative test results for Vitamin D, testosterone, TSH, Free T4, PSA and hCG.

The move will expand Sekisui’s point of care testing portfolio and Sekisui will assume all commercial and distribution duties immediately. — Anisa Jibrell